Literature DB >> 27885309

Transcranial Direct Current Stimulation Use in the Treatment of Neuropsychiatric Disorders: A Brief Review.

Sarah M Szymkowicz1, Molly E McLaren1, Uma Suryadevara2, Adam J Woods3.   

Abstract

Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that has grown in popularity over the past two decades as an alternative treatment option for various neuropsychiatric disorders. tDCS modulates cortical excitability through the application of a weak direct current to the scalp via electrodes placed over cortical regions of interest. It has been shown to be a promising and relatively safe treatment tool with few adverse events. In this article, we will briefly review the efficacy of tDCS in depression, bipolar disorder, schizophrenia, and obsessive-compulsive disorder. We will also discuss biomarkers of tDCS efficacy in depression, as it is the most studied neuropsychiatric disorder using tDCS application. We will then offer suggestions for future directions. Although efficacy results show promise, more studies with larger samples and longer treatment periods are needed to better understand the benefits of using tDCS as an alternative treatment option for neuropsychiatric disorders.

Entities:  

Year:  2016        PMID: 27885309      PMCID: PMC5117191          DOI: 10.3928/00485713-20161006-01

Source DB:  PubMed          Journal:  Psychiatr Ann        ISSN: 0048-5713


  35 in total

1.  Treatment of major depression with transcranial direct current stimulation.

Authors:  Felipe Fregni; Paulo S Boggio; Michael A Nitsche; Marco A Marcolin; Sergio P Rigonatti; Alvaro Pascual-Leone
Journal:  Bipolar Disord       Date:  2006-04       Impact factor: 6.744

2.  Fronto-temporal transcranial Direct Current Stimulation (tDCS) reduces source-monitoring deficits and auditory hallucinations in patients with schizophrenia.

Authors:  Marine Mondino; Frédéric Haesebaert; Emmanuel Poulet; Marie-Françoise Suaud-Chagny; Jérôme Brunelin
Journal:  Schizophr Res       Date:  2014-11-21       Impact factor: 4.939

3.  Hypomania induction in a patient with bipolar II disorder by transcranial direct current stimulation (tDCS).

Authors:  Verònica Gálvez; Angelo Alonzo; Donel Martin; Philip B Mitchell; Perminder Sachdev; Colleen K Loo
Journal:  J ECT       Date:  2011-09       Impact factor: 3.635

4.  Pilot study of feasibility of the effect of treatment with tDCS in patients suffering from treatment-resistant depression treated with escitalopram.

Authors:  D Bennabi; M Nicolier; J Monnin; G Tio; L Pazart; P Vandel; E Haffen
Journal:  Clin Neurophysiol       Date:  2014-10-05       Impact factor: 3.708

Review 5.  Transcranial magnetic stimulation, transcranial direct current stimulation and electroconvulsive therapy for medication-resistant psychosis of schizophrenia.

Authors:  Wendy Nieuwdorp; Sanne Koops; Metten Somers; Iris E C Sommer
Journal:  Curr Opin Psychiatry       Date:  2015-05       Impact factor: 4.741

Review 6.  A technical guide to tDCS, and related non-invasive brain stimulation tools.

Authors:  A J Woods; A Antal; M Bikson; P S Boggio; A R Brunoni; P Celnik; L G Cohen; F Fregni; C S Herrmann; E S Kappenman; H Knotkova; D Liebetanz; C Miniussi; P C Miranda; W Paulus; A Priori; D Reato; C Stagg; N Wenderoth; M A Nitsche
Journal:  Clin Neurophysiol       Date:  2015-11-22       Impact factor: 3.708

7.  Transcranial direct current stimulation in severe, drug-resistant major depression.

Authors:  R Ferrucci; M Bortolomasi; M Vergari; L Tadini; B Salvoro; M Giacopuzzi; S Barbieri; A Priori
Journal:  J Affect Disord       Date:  2009-03-16       Impact factor: 4.839

8.  Augmentative transcranial direct current stimulation (tDCS) in poor responder depressed patients: a follow-up study.

Authors:  Bernardo Dell'Osso; Cristina Dobrea; Chiara Arici; Beatrice Benatti; Roberta Ferrucci; Maurizio Vergari; Alberto Priori; A Carlo Altamura
Journal:  CNS Spectr       Date:  2013-08-20       Impact factor: 3.790

9.  A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression.

Authors:  Paulo S Boggio; Sergio P Rigonatti; Rafael B Ribeiro; Martin L Myczkowski; Michael A Nitsche; Alvaro Pascual-Leone; Felipe Fregni
Journal:  Int J Neuropsychopharmacol       Date:  2007-06-11       Impact factor: 5.176

10.  A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression.

Authors:  Colleen K Loo; Perminder Sachdev; Donel Martin; Melissa Pigot; Angelo Alonzo; Gin S Malhi; Jim Lagopoulos; Philip Mitchell
Journal:  Int J Neuropsychopharmacol       Date:  2009-08-12       Impact factor: 5.176

View more
  9 in total

1.  Augmenting cognitive training in older adults (The ACT Study): Design and Methods of a Phase III tDCS and cognitive training trial.

Authors:  Adam J Woods; Ronald Cohen; Michael Marsiske; Gene E Alexander; Sara J Czaja; Samuel Wu
Journal:  Contemp Clin Trials       Date:  2017-12-05       Impact factor: 2.226

Review 2.  The effects of medication use in transcranial direct current stimulation: A brief review.

Authors:  Molly E McLaren; Nicole R Nissim; Adam J Woods
Journal:  Brain Stimul       Date:  2017-10-12       Impact factor: 8.955

3.  Effect of transcranial direct current stimulation combined with cognitive training on cognitive functioning in older adults with HIV: A pilot study.

Authors:  Pariya L Fazeli; Adam J Woods; Caitlin N Pope; David E Vance; Karlene K Ball
Journal:  Appl Neuropsychol Adult       Date:  2017-10-11       Impact factor: 2.248

Review 4.  Non-invasive Brain Stimulation: Probing Intracortical Circuits and Improving Cognition in the Aging Brain.

Authors:  Joyce Gomes-Osman; Aprinda Indahlastari; Peter J Fried; Danylo L F Cabral; Jordyn Rice; Nicole R Nissim; Serkan Aksu; Molly E McLaren; Adam J Woods
Journal:  Front Aging Neurosci       Date:  2018-06-08       Impact factor: 5.750

Review 5.  Beyond the target area: an integrative view of tDCS-induced motor cortex modulation in patients and athletes.

Authors:  Edgard Morya; Kátia Monte-Silva; Marom Bikson; Zeinab Esmaeilpour; Claudinei Eduardo Biazoli; Andre Fonseca; Tommaso Bocci; Faranak Farzan; Raaj Chatterjee; Jeffrey M Hausdorff; Daniel Gomes da Silva Machado; André Russowsky Brunoni; Eva Mezger; Luciane Aparecida Moscaleski; Rodrigo Pegado; João Ricardo Sato; Marcelo Salvador Caetano; Kátia Nunes Sá; Clarice Tanaka; Li Min Li; Abrahão Fontes Baptista; Alexandre Hideki Okano
Journal:  J Neuroeng Rehabil       Date:  2019-11-15       Impact factor: 4.262

6.  Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning.

Authors:  Pejman Sehatpour; Clément Dondé; Matthew J Hoptman; Johanna Kreither; Devin Adair; Elisa Dias; Blair Vail; Stephanie Rohrig; Gail Silipo; Javier Lopez-Calderon; Antigona Martinez; Daniel C Javitt
Journal:  Neuroimage       Date:  2020-09-01       Impact factor: 6.556

7.  The safety and efficacy of transcranial direct current stimulation as add-on therapy to fluoxetine in obsessive-compulsive disorder: a randomized, double-blind, sham-controlled, clinical trial.

Authors:  Sadegh Yoosefee; Man Amanat; Mona Salehi; Seyed Vahid Mousavi; Jamshid Behzadmanesh; Victoria Safary; Ali Yoonesi; Bahman Salehi
Journal:  BMC Psychiatry       Date:  2020-11-30       Impact factor: 3.630

8.  Transcranial Random Noise Stimulation for the Acute Treatment of Depression: A Randomized Controlled Trial.

Authors:  Stevan Nikolin; Angelo Alonzo; Donel Martin; Veronica Gálvez; Sara Buten; Rohan Taylor; James Goldstein; Cristal Oxley; Dusan Hadzi-Pavlovic; Colleen K Loo
Journal:  Int J Neuropsychopharmacol       Date:  2020-04-21       Impact factor: 5.176

9.  Machine learning and individual variability in electric field characteristics predict tDCS treatment response.

Authors:  Alejandro Albizu; Ruogu Fang; Aprinda Indahlastari; Andrew O'Shea; Skylar E Stolte; Kyle B See; Emanuel M Boutzoukas; Jessica N Kraft; Nicole R Nissim; Adam J Woods
Journal:  Brain Stimul       Date:  2020-10-10       Impact factor: 8.955

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.